Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5;13(1):5560.
doi: 10.1038/s41598-023-32768-1.

Secondary oxidized di-2-ethylhexyl phthalate metabolites may be associated with progression from isolated premature thelarche to central precocious or early puberty

Xiuxin Zheng #  1   2 , Huiping Su #  1 , Shurong Huang  1   3 , Wei Su  1 , Rongfei Zheng  1 , Yue Shang  1 , Qiru Su  4 , Li Zhou  5 , Yao Yao  6 , Zhe Su  7
Affiliations

Secondary oxidized di-2-ethylhexyl phthalate metabolites may be associated with progression from isolated premature thelarche to central precocious or early puberty

Xiuxin Zheng et al. Sci Rep. .

Abstract

Phthalate esters (PAEs) may act as estrogen receptor agonists, and their relationship with precocious puberty is a global health concern. However, their role in isolated premature thelarche (IPT) progression remains unclear. We conducted a cohort study investigating the relationship between IPT progression and urinary PAE metabolites. Girls with IPT aged 6-8 years were regularly followed up every three months for one year. Clinical data and urine PAE metabolite levels were collected. Participants who progressed to central precocious puberty (CPP) or early puberty (EP) had significantly higher ovarian volume, breast Tanner stage, and levels of the creatinine-adjusted urinary secondary oxidized di-2-ethylhexyl phthalate (DEHP) metabolites (Σ4DEHP). Breast Tanner stage (odds ratio [OR] = 7.041, p = 0.010), ovarian volume (OR = 3.603, p = 0.019), and Σ4DEHP (OR = 1.020, p = 0.005) were independent risk factors for IPT progression. For each 10 µg/g/Cr increase in the urine level of Σ4DEHP, the risk of progression from IPT to CPP/EP within one year increased by 20%. This study demonstrated that the breast Tanner stage, ovarian volume, and Σ4DEHP in urine were independent risk factors for IPT progression, and Σ4DEHP may be associated with the progression of IPT to CPP or EP.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart of the study population selection process. IPT isolated premature thelarche, CPP central precocious puberty.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Farello G, Altieri C, Cutini M, Pozzobon G, Verrotti A. Review of the literature on current changes in the timing of pubertal development and the incomplete forms of early puberty. Front. Pediatr. 2019;7:147. doi: 10.3389/fped.2019.00147. - DOI - PMC - PubMed
    1. Lanciotti L, Cofini M, Leonardi A, Penta L, Esposito S. Up-to-date review about minipuberty and overview on hypothalamic-pituitary-gonadal axis activation in fetal and neonatal life. Front. Endocrinol. Lausanne. 2018;9:410. doi: 10.3389/fendo.2018.00410. - DOI - PMC - PubMed
    1. Zhu S, Du M, Lin A. An analysis of risk factors for premature thelarche converting into central precious puperty. Chin. J. Pract. Clin. Pediatr. 2008;23:174–176.
    1. Su H, et al. Factors affecting bone maturation in Chinese girls aged 4–8 years with isolated premature thelarche. BMC Pediatr. 2020;20:356. doi: 10.1186/s12887-020-02256-w. - DOI - PMC - PubMed
    1. Uçar A, et al. Is premature thelarche in the first two years of life transient? J. Clin. Res. Pediatr. Endocrinol. 2012;4:140–145. doi: 10.4274/Jcrpe.709. - DOI - PMC - PubMed

Publication types

-